Bernie Sanders launched a Senate probe into high prices for Ozempic and WegovyByBruce GilUpdatedApril 25, 2024
UnitedHealth Group says it paid a ransom to protect patient data from a cyberattackByBruce GilUpdatedApril 23, 2024
Luxury home prices hit a record as half of wealthy buyers pay in cashByBruce GilPublishedApril 22, 2024
Apple, Amazon, Nvidia, and other Big Tech stocks could see their profit growth 'collapse,' UBS saysByBruce GilPublishedApril 22, 2024
One of Europe's biggest banks is selling Tesla, Apple and Microsoft stockByBruce GilUpdatedApril 22, 2024
Warner Bros. Discovery CEO David Zaslav got paid $50 million even as the company lost moneyByBruce GilPublishedApril 19, 2024
Air traffic controllers will have to take a 10-hour break between shifts to avoid fatigueByBruce GilPublishedApril 19, 2024
Procter & Gamble hiked prices — and then Pampers and Bounty sales dippedByBruce GilPublishedApril 19, 2024
Fake Ozempic sites, more Zepbound shortage, and J&J 's sales miss: Pharma news roundupByBruce GilPublishedApril 19, 2024
Even more doses of Eli Lilly's Zepbound and Mounjaro are officially in a shortage, FDA saysByBruce GilPublishedApril 17, 2024
Eli Lilly's weight loss drug Zepbound could help treat sleep apnea — paving a way to Medicare coverageByBruce GilUpdatedApril 17, 2024
People are giving up on Amazon Prime Video shows because of catalog errors, report saysByBruce GilUpdatedApril 16, 2024
Johnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectationsByBruce GilUpdatedApril 16, 2024
